Contact
日本語
Business
Next-Gen Medicine
Next-Gen Medicine
Pipeline
Technology/Program
Business Development
News
About Us
Career
Business
Next-Gen Medicine
Pipeline
Technology/Program
Business Development
News
About Us
Career
Contact
日本語
News
HOME
News
Release
Media
Stage
Other
2021.09.27
Release
Obtained type 2 medical device manufacturing and sales license and medical device manufacturing license.
2021.05.26
Release
Selected as an AMED “Medical Innovation Promotion Project (Development and Commercialization Project) for Venture Development”.
2021.05.25
Release
“Non-clinical research on the improvement of the accuracy of bacterial species classification of bacterial infections and the appropriate use of antimicrobial drugs using image recognition AI” was adopted as a “Research Project for the Promotion of Medical Device Development”.
2021.05.06
Release
Selected for the 37th international conference of the European Society for Human Reproductive Research (ESHRE).
2021.03.29
Release
A subsidiary company, CarbGeM Inc. was established to address antimicrobial resistance.
2021.01.20
Release
Announced the interim evaluation results of Cyclic Innovation for Clinical Empowerment (CiCLE) at AMED
2020.12.15
Stage
Accepted for the Annual Meeting of the Japanese Society for Reproductive Medicine (JSRM).
2020.11.01
Stage
Invited lecturer for AI and Advanced Programming Consortium course “Introduction to AI Medicine” at Keio University.
2020.10.21
Release
Joint R&D with National Center for Global Health and Medicine and Kobe University to estimate the bacterial species of infectious diseases and to support the selection of antimicrobial drugs by using AI.
2020.10.01
Release
CSO Miyanishi was appointed as a mentor for ANCHOR KOBE.
2020.09.23
Release
Joint R&D with Kyoto University for early diagnosis of malignant hematological diseases
2020.07.10
Stage
Accepted for the 36th international conference of the European Society for Human Reproductive Research (ESHRE).
2020.04.27
Other
Obtained Information Security Management System （ISMS） certification.
2019.11.24
Stage
Presented “Establishment of a Predictive Model of GvHD-free, Relapse-free Survival after Allogeneic Hematopoietic Stem Cell Transplantation using a Machine Learning Algorithm” at American Society of Hematology (ASH).
2019.11.20
Release
Announced equity and business relationship with Sumitomo Dainippon Pharma Co., Ltd.(currently:Sumitomo Pharma Co., Ltd.).
2019.11.01
Stage
“Prediction accuracy results of transferring time-lapse observed embryos using artificial intelligence (AI) and Machine Learning Algorithms” was accepted as a subject for the Annual Meeting of the Japanese Society for Reproductive Medicine.
2019.04.26
Release
“Development of in vitro expansion technology for hematopoietic stem cells and its application to transplantation medicine” was selected for Cyclic Innovation for Clinical Empowerment (CiCLE) at AMED.
2019.04.01
Other
Suguru Namura, experienced in new business development, was appointed as system architect.
2019.04.01
Other
Ayako Kawatake, a presenter at the 163rd BIE Annual Meeting, was appointed as a communication ambassador.
2019.03.01
Other
Selected as Microsoft for Startups.
< prev
1
2
3
next >
